RMFCX
Price
$62.20
Change
+$0.11 (+0.18%)
Updated
Oct 6 closing price
Net Assets
112.47B
VECRX
Price
$21.95
Change
-$0.02 (-0.09%)
Updated
Oct 6 closing price
Net Assets
170.63M
Interact to see
Advertisement

RMFCX vs VECRX

Header iconRMFCX vs VECRX Comparison
Open Charts RMFCX vs VECRXBanner chart's image
American Funds American Mutual R3
Price$62.20
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets112.47B
Virtus KAR Equity Income R6
Price$21.95
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets170.63M
RMFCX vs VECRX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. VECRX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Hold and VECRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. VECRX (171M). VECRX pays higher dividends than RMFCX: VECRX (4.64) vs RMFCX (1.20). RMFCX was incepted earlier than VECRX: RMFCX (23 years) vs VECRX (8 years). VECRX (1.04) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 31.00 vs. VECRX (17.00). RMFCX has a lower initial minimum investment than VECRX: RMFCX (250) vs VECRX (2500000). VECRX annual gain was more profitable for investors over the last year : 8.18 vs. RMFCX (7.44). RMFCX return over 5 years is better than : 60.80 vs. VECRX (8.21).
RMFCXVECRXRMFCX / VECRX
Total Expense Ratio0.910.78117%
Annual Report Gross Expense Ratio0.911.0488%
Fund Existence23 years8 years-
Gain YTD14.96411.746127%
Front LoadN/AN/A-
Min. Initial Investment25025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets112B171M65,497%
Annual Yield % from dividends1.204.6426%
Returns for 1 year7.448.1891%
Returns for 3 years43.8434.92126%
Returns for 5 years60.808.21740%
Returns for 10 years94.21N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFPT201.936.71
+3.44%
UFP Technologies
VMI400.365.74
+1.45%
Valmont Industries
FRMEP25.80N/A
N/A
First Merchants Corp
LXEO6.47-0.15
-2.27%
Lexeo Therapeutics
KPTI6.16-0.22
-3.45%
Karyopharm Therapeutics Inc.